Prime-LS: a cryoprotectant-free, lyophilized MSC-secretome conferring protection against acute experimental colitis in vivo
Trends in Biotechnology · 2026-11
DOI: 10.1016/j.tibtech.2026.10.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Biotechnology, 2026-11. Verfasst von Maria Rossello-Gelabert und 6 weiteren Autor:innen. Beteiligte Einrichtung: NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01…. Die Arbeit nennt 63 Literaturangaben. Gefördert von: Basque Government, AEI.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NanoBioCel Research Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Paseo de la Universidad 7, 01006 Vitoria-Gasteiz, Spain; Bioaraba, NanoBioCel Research Group, Vitor…
- Pathological Anatomy Service, Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, Vitoria-Gasteiz, Spain.
Förderung
- Basque Government
- AEI
Zitieren
APA
Rossello-Gelabert, M., Garcia-Blasco, C., Aguirre, J. J., Gonzalez-Pujana, A., Igartua, M., Santos-Vizcaino, E., & Hernandez, R. M. (2026). Prime-LS: a cryoprotectant-free, lyophilized MSC-secretome conferring protection against acute experimental colitis in vivo. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2026.10.015
Vancouver
Rossello-Gelabert M, Garcia-Blasco C, Aguirre JJ, Gonzalez-Pujana A, Igartua M, Santos-Vizcaino E, et al. Prime-LS: a cryoprotectant-free, lyophilized MSC-secretome conferring protection against acute experimental colitis in vivo. Trends in Biotechnology. 2026. doi:10.1016/j.tibtech.2026.10.015
BibTeX
@article{RosselloGelabert2026,
author = {Rossello-Gelabert, Maria and Garcia-Blasco, Camino and Aguirre, Jose Javier and Gonzalez-Pujana, Ainhoa and Igartua, Manoli and Santos-Vizcaino, Edorta and Hernandez, Rosa Maria},
title = {Prime-LS: a cryoprotectant-free, lyophilized MSC-secretome conferring protection against acute experimental colitis in vivo},
journal = {Trends in Biotechnology},
year = {2026},
doi = {10.1016/j.tibtech.2026.10.015}
}
EUVIMED